13G Filing: Healthcor Management LP and Bioverativ Inc (BIVV)

Page 13 of 17

Page 13 of 17 – SEC Filing

CUSIP
No. 097075E100
13G Page
13 of 17 Pages
Item 1(a). Name of Issuer:
Bioverativ, Inc.
Item 1(b).   Address of Issuer’s Principal Executive Offices:
225 Second Avenue, Waltham, MA 02451
Item 2(a, b, c). Name of Person Filing:
(i)  HealthCor Management, L.P., a Delaware limited partnership,
Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
(ii)  HealthCor Associates, LLC, a Delaware limited liability
company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
(iii)  HealthCor Offshore Master Fund, L.P., a Cayman Islands
limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
(iv)  HealthCor Offshore GP, LLC, a Delaware limited liability
company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
(v)  HealthCor Group, LLC, a Delaware limited liability
company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
(vi)   Joseph Healey, Carnegie Hall Tower, 152
West 57th Street, 43rd Floor, New York, New York 10019;
(vii)  Arthur Cohen, 12 South Main Street, #203 Norwalk,
CT 06854;
(viii)   HealthCor Sanatate Offshore Master Fund, L.P.,
a Cayman Islands limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
(ix)  HealthCor Offshore II GP, LLC, a Delaware limited
liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
(x)   HealthCor Co-Invest Sanatate Master Fund,
L.P., a Cayman Islands limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019;
and
(xi)   HealthCor Offshore III GP, LLC, a Delaware
limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019.
Both Mr. Healey and Mr. Cohen are United States citizens.
The persons at (i) through (xi) above are collectively referred
to herein as the “Reporting Persons”.

Follow Bioverativ Inc.

Page 13 of 17